Through the existing Innovator in Residence (IIR) program, HIMSS and the U.S. Department of Health and Human Services (HHS) are collaborating to move forward on the creation of a nationwide patient data matching strategy.
The U.S. Food and Drug Administration (FDA) granted U.S. market approval for Medtronic’s self-expanding transcatheter aortic valve replacement (TAVR) CoreValve System. It is the first self-expanding TAVR valve to be approved in the United States and the second TAVR valve to achieve FDA approval.
Cardiothoracic and Vascular Surgeons (CTVS) is the first practice in Texas to implant a Sorin Perceval S self-anchoring aortic heart valve as part of a new clinical trial.
If you enjoy this content, please share it with a colleague
Providers report that despite vendor efforts, clinical decision support (CDS) reference products are still not integrated enough to deliver the strategic direction providers are looking for.
In a move that calls into question the future of transcatheter valve competition in the United States, a jury in the Federal District Court of Delaware decided Jan. 15 the Medtronic CoreValve infringes on transcatheter device patents held by Edwards Lifesciences Corp. Medtronic said it intends to appeal the decision.
If you enjoy this content, please share it with a colleague
A new “fluid biopsy” technique that could identify patients at high risk of a heart attack by identifying specific cells as markers in the bloodstream has been developed by a group of researchers at The Scripps Research Institute (TSRI).
A new magnetic resonance imaging (MRI) method to map creatine at higher resolutions in the heart may help clinicians and scientists find abnormalities and disorders earlier than traditional diagnostic methods.
If you enjoy this content, please share it with a colleague